Professional Documents
Culture Documents
3
Transdermal drug delivery system is defined as self
containing, discrete dosage forms which when applied
to the intact skin,deliver the drugs through the skin at a
controlled rate to the systemic circulation.
4
Avoid gastrointestinal drug absorption difficulties caused
by gasrtointestinal pH, enzymatic activity, drug
interaction.
Substitute for oral administration of medication.
Avoid first pass effect.
Noninvasive in nature.
Extended therapy with a single application.
Improving compliance.
May be terminated rapidly.
Easily and rapidly identified in emergencies.
5
Many drugs especially drugs with hydrophilic structures
permeate the skin too slowly may not achieve therapeutic
level.
The drug, the adhesive or other excipients in the patch
formulation can cause erythema, itching and local
edema.
The barrier function of the skin changes from one site to
another on the same person, from person to person and
also with age.
Drug that require high blood levels cannot be
administered
Adhesive may not adhere well to all types of skin
6
Bioactivity of drug
Skin characteristics
Formulation
Adhesion
System design
7
Release of the medicament from the vehicle.
Penetration through the skin barrier.
› Skin structure and its properties
› The penetrating molecule and its physical-chemical
relationship to skin and the delivery platform
› The platform or delivery system carrying the
penetrant
› The combination of skin, penetrant, and delivery
system
Activation of pharmacological response.
8
o Biological factors –
o Skin condition
o Skin age
o Blood flow
o Skin metabolism
o Species differences
9
Physicochemical factors –
Skin hydration
Temperature and pH
Diffusion coefficient
Drug concentration
Partition coefficient
Molecular shape and size
10
11
1.Through stratum
corneum
2.Transfollicular
3.Through sweat
gland
12
The drug
Polymer matrix
Permeation enhancers
Adhesive
Backing layer.
13
The drug is in direct contact with release liner.
Ex: Nicotine, Methotrexate, and Oestrogen.
15
Substances exist which temporarily diminish the
impermeability of the skin are known as accelarants or
sorption promoters or penetration enhancers.
16
Serves to adhere the patch to the skin for systemic drug
delivery of the drug
17
Backing layer protects patch from outer environment.
18
19
There are main four types of TDDS
25
1. Prausnitz MR, Mitragotri S, Langer R. Current status
and future potential of transdermal drug delivery.t Rev
Drug Discov. 2004;3:115–124.
2. Bronaugh RL, Maibach HI, editors. Edn. 4th. New York:
Marcel Dekker; 2005. Percutaneous Absorption.
3. Jain N.K. ,Pharmaceutical Product Development, First
edition,CBS publishers
4. Aulton.M.E, Pharmaceutics; The science of dosage form
design, second edition, Marcel Dekker;2002.502-505.
26
5. Allen L.V.; Ansel.H.C ;Popovich.N.G ,Pharmaceutical
dosage forms and drug delivery systems, Ninth edition,
Lippincott Williams and Wilkins publication,2011,295.
27
28